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Objective Results and discussion
Methods
Conclusions
This final degree project is intended to be a compilation of the current scientific literature revolving paraneoplastic 
syndromes (PNS) in canine medicine, their known incidences, associated neoplasms and proposed functioning 
mechanism. It also intends to reflect the perception of PNS by Spanish veterinarians in their clinical cases, using it as a 
base to compare both literature and professionals’ perception. 
Emphasize the goal of the study. 
Some discrepancies have been found when compared certain results with the current literature. 
Regarding protein-losing enteropathy and leukocytosis,  the incidence is higher when asked to 
veterinarians than that described in literature. The exact opposite happens with hypoglycemia. 
   
Information in literature is scant regarding cutaneous flushing, glomerulonephritis, dermatomyositis, 
retinopathies, optic neuropathies and nephrotic syndrome, so no comparison was possible.  
 
Introduction
Syndrome
Percentage of 
vets who 
encountered it
Perception 
of incidence
Syndrome
Percentage of 
vets who 
encountered it
Perception 
of incidence
Cancer cachexia 71% Frequent Glomerulonephritis 38% Rare
Protein-losing 
enteropathy
69% Frequent Nephrotic 
syndrome
38% Rare
Gastroduodenal 
ulceration
67% Frequent Myastenia gravis 33% Rare
Hypercalcemia of 
malignancy
57% Frequent Hyperglycemia 31% Rare
Anemia 57% Frequent Nodular 
dermatofibrosis
26% Rare
Leukocytosis 57% Frequent Diabetes insipidus 26% Rare
Thrombocytopenia 57% Frequent
Superficial 
necrolytic 
dermatitis
24% Rare
Coagulopathies 52% Frequent Diencephalic 
syndrome
24% Rare
Hyperglobulinemia 50% Frequent Retinopathies 24% Rare
Cutaneous flushing 50% Frequent Ectopic Cushing 
syndrome
21% Rare
Hypoglycemia 57% Rare Pemphigus 21% Rare
Peripheral 
neuropathies
50% Rare Optic neuropathies 21% Rare
Erythrocytosis 48% Rare SIADH 17% Rare
Uveitis 48% Rare Dermatomyositis 10% Rare
- A PNS is a neoplasm-associated alteration in bodily structure 
or function that occurs distant to the tumor. 
- They are a relatively new area of study revolving cancer.
- Pathogenesis varies among syndromes but several humoral 
and immune mediators are implicated, as well as the tumors’ 
acquired ability to secrete a variety of bioactive substances.
- Signs of the PNS may be what actually prompt veterinary 
evaluation in the first place.
- They have been described in many species and affecting a 
large variety of organs and tissues and they have been proved 
to have a very important role in early recognition of the 
disease as well as in its course, its treatment and its prognosis.
- Table 1 summarizes the known data regarding PNS and their 
associated tumors, incidence and main mechanisms.
- In nephrotic syndrome, retinopathies, optic neuropaties and 
dermatomyositis; incidence, mechanisms and associated 
tumors are unknown. 
Table 1
MCT, mast cell tumor; SIADH, syndrome of inappropriate secretion of antidiuretic hormone; ADH, anti-diuretic hormone; ACTH, adrenocorticotropic 
hormone; DIC, disseminated intravascular coagulation.
A survey was composed regarding PNS and their presence in the 
professional activity of Spanish veterinarian doctors. It was 
answered by 42 veterinarians.
The survey is formed by two main parts:
- Signaling PNS they had encountered from a basic classification 
(gastrointestinal, endocrine, hematological, dermatological, renal, 
neurological, ophthalmological and musculoskeletal).
- Estimate frequencies about concrete syndromes depending on 
the previous answer.
The frequency was estimated in a scale of 1 to 5 (1=never; 
2=very rarely; 3=few times; 4=every now and then; 
5=frequently). 
The percentage of veterinarians who say to have 
encountered uveitis, diencephalic syndrome, 
pemphigus and superficial necrolytic dermatitis 
as a PNS is very shocking when compared to the 
literature, as little few cases have been described 
whereas respondents claim to have found them 
quite often.
The rest of the results are not far from what 
expected when comparing them the literature. 
The results of the survey are summarized in 
Table 2. The middle column refers to what 
percentage of the 42 par ticipants ever 
encountered a particular PNS whereas the right 
column reflects the frequency in which the 
participants that encountered this particular 
syndrome believe they stand in front of it 
amongst their oncological cases. 
Table 2
The disparity between information obtained from the survey and that obtained from literature may be 
explained by: 
- Misinformation: clinicians will rarely identify signs or symptoms they have never heard of.
- Not all existing cases are published.
- Disinterest of respondents for somebody else's work may result in erroneous or invented answers.
- Misunderstanding of the survey could lead to unintended error. Human element must always be taken 
into account. 
More studies are needed in order to achieve better knowledge in that field. 
Syndrome Main tumors Incidence
Most probable 
mechanism
Cancer cachexia Multiple tumors Frequent Hormonal or cytokine-mediated 
Gastroduodenal 
ulceration
MCT, gastrinoma Up to 75% of dogs with MCT
Excess histamine 
production
Protein-losing 
enteropathy
Gastrointestinal 
neoplasms Rare
Mucosal erosion, 
ulceration or lymphatic 
obstruction
Hypercalcemia of 
malignancy
Lymphoma and others Frequent Ectopic production of PTH
Hypoglycemia Insulinoma and others Frequent Hyperinsulinemia
SIADH Hypothalamic tumor Rare
Ectopic/excessive 
production ADH/ADH-
like molecule
Ectopic Cushing 
syndrome
Primary lung tumors Rare Ectopic ACTH secretion
Hyperglycemia
Pituitary tumors, 
adrenocortical tumors, 
glucagonoma
Rare
Production of several 
hormones by the tumor 
or resistance to insulin
Hyperglobulinemia
Multiple myeloma, 
plasmacitoma, 
lymphoma, leukemia
Frequent Excessive production of immunoglobulins
Anemia Multiple tumors Frequent Depends on the kind of anemia
Erythrocytosis
Kidney, lung or liver, 
lymphoma and others Rare
Primary erythropoietin 
excessive production or 
secondary to renal 
hypoxia
Leukocytosis
Lymphoma, 
fibrosarcoma, 
carcinomas
Rare
Production of colony-
stimulating factor or 
cytokines by the tumor
Thrombocytopenia
Spleen tumors, 
lymphoma, leukemia
30% of solid 
tumors and 
58% of 
lymphomas
Anti-platelet antibodies 
and cross-reactivity 
between platelet antigens 
and tumor antigens
DIC
Hemangiosarcoma and 
others Frequent
Coagulation-activating 
substances produced by 
the tumor
Cutaneous flushing
Pheochromocytoma, 
carcinoids, MCT Unknown Unknown
Nodular 
dermatofibrosis
Cystadenocarcinoma, 
cystadenoma
Rare, only in 
German 
Shepherd
Autosomal dominant 
inheritance
Superficial necrolytic 
dermatitis
Glucagonoma, 
glucagon-producing 
pancreatic tumors
Seven reported 
cases
Hypoaminoacidemia 
secondary to chronic 
glucagon elevation
Pemphigus
Mediastinal lymphoma 
and splenic sarcoma
Two reported 
cases
Autoimmune process 
initiated by 
lymphoproliferative 
disorder
Diabetes insipidus Leiomyosarcoma Rare Unknown
Glomerulonephritis
Polycythemia vera, 
leukemia and others Unknown
Immune complex or 
amyloid deposition and 
hypercalcemia
Myastenia gravis Thymoma Up to 47% Autoantibodies bound to acetylcholine receptors
Peripheral 
neuropathies
Insulinoma, leukemia, 
lymphoma and others Unknown
Insulin excess causing 
sustained hypoglycemia
Uveitis Renal lymphoma One possible case Immune-mediated
Hypertrophic 
osteopathy
Lung tumors, osteo-
sarcoma and others Unknown
Vasoactive substances 
secreted by the tumor or 
neurological stimulation
Fever Lymphoma and others Unknown
Production of 
endogenous pyrogens 
(IL-1, IL-6, TNF-α)
Table 1
SIADH, syndrome of inappropriate secretion of antidiuretic hormone.
MCT, mast cell tumor; SIADH, syndrome of inappropriate secretion of antidiuretic hormone; ADH, anti-diuretic 
hormone; ACTH, adrenocorticotropic hormone; DIC, disseminated intravascular coagulation.
